Search Results - "Burns, Virginia A"

Abstract 4015: A comparative study of PD-L1 IHC 22C3 and 28-8 FDA-approved diagnostic assays in cancer by Batenchuk, Cory, Albitar, Maher, Sudarsanam, Sucha, Chizhevsky, Vladislav, Jin, Chelsea, Burns, Virginia A.

“…Abstract Background: Higher levels of PD-L1 expression at the surface of tumor cells have been associated with increased response to anti-PD-1 therapies…”
Get full text

Phosphoproteomic profiling of human myocardial tissues distinguishes ischemic from non-ischemic end stage heart failure by Schechter, Matthew A, Hsieh, Michael K H, Njoroge, Linda W, Thompson, J Will, Soderblom, Erik J, Feger, Bryan J, Troupes, Constantine D, Hershberger, Kathleen A, Ilkayeva, Olga R, Nagel, Whitney L, Landinez, Gina P, Shah, Kishan M, Burns, Virginia A, Santacruz, Lucia, Hirschey, Matthew D, Foster, Matthew W, Milano, Carmelo A, Moseley, M Arthur, Piacentino, 3rd, Valentino, Bowles, Dawn E

“…The molecular differences between ischemic (IF) and non-ischemic (NIF) heart failure are poorly defined. A better understanding of the molecular differences…”
Get full text

Mimicking the biological activity of diazobenzo[ b]fluorene natural products with electronically tuned diazofluorene analogs by Zeng, Wei, Eric Ballard, T., Tkachenko, Alexander G., Burns, Virginia A., Feldheim, Daniel L., Melander, Christian

“…The synthesis, DNA cleaving, and anti-proliferative properties of electronically modulated diazofluorenes are reported. Under appropriate electronic…”
Get full text

Targeting RNA with cysteine-constrained peptides by Burns, Virginia A., Bobay, Benjamin G., Basso, Anne, Cavanagh, John, Melander, Christian

“…Non poly-cationic cyclic peptides that target RNA are presented. A combined approach for targeting RNA with novel, biologically active ligands has been…”
Get full text